相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Developing combination immunotherapies for type 1 diabetes: recommendations from the ITN-JDRF Type 1 Diabetes Combination Therapy Assessment Group
J. B. Matthews et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Immunotherapy of Type 1 Diabetes: Where Are We and Where Should We Be Going?
Xunrong Luo et al.
IMMUNITY (2010)
The honeymoon phase: intersection of metabolism and immunology
Hanan Aly et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2009)
Diabetes Antibody Standardization Program:: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2
C. Torn et al.
DIABETOLOGIA (2008)
Histone deacetylase inhibitors modify pancreatic cell fate determination and amplify endocrine progenitors
Cecile Haumaitre et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Deacetylase inhibition promotes the generation and function of regulatory T cells
Ran Tao et al.
NATURE MEDICINE (2007)
A randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of topiramate controlled release in the treatment of obese type 2 diabetic patients
Julio Rosenstock et al.
DIABETES CARE (2007)
Topiramate in the treatment of obese subjects with drug-naive type 2 diabetes
K. Stenlof et al.
DIABETES OBESITY & METABOLISM (2007)
Inhibition of histone deacetylases prevents cytokine-induced toxicity in beta cells
L. Larsen et al.
DIABETOLOGIA (2007)
High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes
Raffaella Buzzetti et al.
DIABETES CARE (2007)
FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression
Bin Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Efficacy and safety of topiramate in combination with metformin in the treatment of obese subjects with type 2 diabetes: a randomized, double-blind, placebo-controlled study
H. Toplak et al.
INTERNATIONAL JOURNAL OF OBESITY (2007)
The antiepileptic drug topiramate preserves metabolism-secretion coupling in insulin secreting cells chronically exposed to the fatty acid oleate
Francesca Frigerio et al.
BIOCHEMICAL PHARMACOLOGY (2006)
An association between type 1 diabetes and idiopathic generalized epilepsy
D McCorry et al.
ANNALS OF NEUROLOGY (2006)
Topiramate ameliorates hyperglycaemia and improves glucose-stimulated insulin release in ZDF rats and db/db mice
Y Liang et al.
DIABETES OBESITY & METABOLISM (2005)
IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71)
GF Bottazzo et al.
DIABETOLOGIA (2005)
Role of histone and transcription factor acetylation in diabetes pathogenesis
ST Gray et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2005)
The activity of antiepileptic drugs as histone deacetylase inhibitors
S Eyal et al.
EPILEPSIA (2004)
A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects
J Wilding et al.
INTERNATIONAL JOURNAL OF OBESITY (2004)
分享论文
